Survival of irradiated recipient mice after transplantation of bone marrow from young, old and "early aging" mice

Aging
Ian GuestStewart Sell

Abstract

Bone marrow transplantation is used to examine survival, hematopoietic stem cell function and pathology in recipients of young and old wild type bone marrow derived stem cells (BMDSCs) as well as cells from p53-based models of premature aging. There is no difference in the long term survival of recipients of 8 week-old p53+/m donor cells compared to recipients of 8 week-old wild-type (WT) donor cells (70 weeks) or of recipients of 16-18 weeks-old donor cells from either p53+/m or WT mice. There is shorter survival in recipients of older versus younger WT donor bone marrow, but the difference is only significant when comparing 8 and 18 week-old donors. In the p44-based model, short term survival/engraftment is significantly reduced in recipients of 11 month-old p44 donor cells compared to 4 week-old p44 or wild type donor cells of either age; mid-life survival at 40 weeks is also significantly less in recipients of p44 cells. BMDSCs are readily detectable within recipient bone marrow, lymph node, intestinal villi and liver sinusoids, but not in epithelial derived cells. These results indicate that recipients of young BMDSCs may survive longer than recipients of old bone marrow, but the difference is marginal at best.

References

May 3, 2003·Ageing Research Reviews·Bruce Richardson
Jan 25, 2007·Cell Cycle·Catherine GatzaLawrence A Donehower
Aug 7, 2007·PLoS Biology·Stuart M ChambersMargaret A Goodell
Mar 29, 2008·Cell Stem Cell·Stuart M ChambersMargaret A Goodell
Jan 1, 2011·Pathobiology of Aging & Age Related Diseases·Christina Pettan-Brewer, Piper M Treuting
May 23, 2015·Pathobiology of Aging & Age Related Diseases·Kaoru Tominaga
Jul 25, 2015·The Biochemical Journal·David W Meek

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
Assay

Software Mentioned

Optronics PictureFrame

Related Concepts

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

© 2022 Meta ULC. All rights reserved